市場調査レポート
商品コード
1084061
凍結保存細胞株の世界市場規模:製品タイプ別、用途別、エンドユーザー別、地域別予測(2022年~2028年)Global Cryopreservation Cell Lines Market Size study, By Product Type, By Application, By End-User, and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
凍結保存細胞株の世界市場規模:製品タイプ別、用途別、エンドユーザー別、地域別予測(2022年~2028年) |
出版日: 2022年05月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の凍結保存細胞株の市場規模は、2021年は約35億6,000万米ドルで、2022年から2028年の予測期間中に11%以上の成長率で成長すると予想されています。
同市場の成長を後押しする主な要因には、ヘルスケア分野の成長、技術開発の増加、臨床および商業的な細胞治療製品の進歩などが挙げられます。一方で、凍結保存細胞株の利用可能性に関する認知度の低さが、予測期間における同市場の成長を抑制する可能性があります。
当レポートでは、世界の凍結保存細胞株市場を調査しており、市場の概要、市場分析、製品タイプ・製品・エンドユーザー・地域別の分析、および競合情勢など、包括的な情報を提供しています。
List of figures
Global Cryopreservation Cell Lines Market is valued at approximately USD 3.56 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11% over the forecast period 2022-2028. Cryopreservation is defined as a method of preservation of the tissues, cells, and other samples at a very low temperature that leads aids in rising sales of cryopreservation cell lines. Cryopreservation cell lines minimize vascular damage caused by blood vessel extension, and therefore it is increasingly used in regenerative and reparative medicine, as well as a cell-based therapy. The growth of the healthcare sector, the increasing number of technological developments, coupled with the rising advancements in clinical and commercial cell therapy products are the several key factors fostering the market demand across the globe. For instance, according to the Indian Brand Equity Foundation, the healthcare sector in India is anticipated to account for a three-fold rise with a CAGR of 22% during the period of 2016-2022 to reach around USD 372 billion in 2022 from USD 110 billion in 2016. Consequentially, the thriving growth of the healthcare sector is boosting the market growth worldwide. However, a lack of awareness regarding the availability of cryopreservation cell lines impedes the growth of the market over the forecast period of 2022-2028. Also, the growing investments in the R&D activities, along with the rising emphasis on the development of tissue engineering and biobanking facilities are anticipated to act as catalyzing factors for the market demand during the forecast period.
The key regions considered for the global Cryopreservation Cell Lines Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to growth of the biotechnology industry and increasing spending on R&D activities. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the development of the healthcare infrastructure, as well as increasing product management operations, would create lucrative growth prospects for the Cryopreservation Cell Lines Market across the Asia-Pacific region.
Major market players included in this report are:
Thermo Fisher Scientific, Inc.
ATCC
Corning Incorporated
ABM Inc
ZenBio
Reprocell USA Inc.
Bio-Techne Corporation
Nippon Sanso Holdings Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Serum-Containing Medium
Serum-free Medium
Cry vials
Reagents
By Application:
Oncology
Immunology
Cell Biology
Others
By End-User:
Diagnostic Laboratories
Biopharmaceutical Companies
Academic & Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Cryopreservation Cell Lines Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors